Quality of Life in Brain Tumor Patients: The Relative Contributions of Depression, Fatigue, Emotional Distress, and Existential Issues
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Neuropsychiatric problems, and how they interact to impact on quality of life (QOL) in brain tumor patients, are generally poorly understood. The objectives of this study were: (1) to document the prevalence of depression, fatigue, emotional distress, and existential issues in a sample of brain tumor patients (2) to examine the interconnectedness of these problems, and (3) to explore their relationship with disease-related variables and QOL. This is a cross-sectional, questionnaire-based survey of 73 patients with primary brain tumors who presented to a neurological clinic at a tertiary cancer centre for ongoing care. Data for 60 participants (29 women, 31 men) who completed validated questionnaires were retained for analysis. Results showed that there was a high burden of depressive symptoms as measured by the Beck Depression Inventory-II (mean score 11.1, SD 7.4), with 38% of the sample scoring in the clinically depressed range. Overall QOL scores for this sample were similar to a reference sample of brain tumor patients. The scores on the existential subscale of the McGill Quality of Life questionnaire were comparable to those of a reference sample of cancer patients receiving ongoing care (mean score 7.2; SD 1.7). Fifty per cent of the sample could be classified as struggling with existential issues. Although scores reflecting depression, fatigue, emotional distress, and existential problems were interrelated, the presence of depressive symptoms was the single most import…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“prevalence rates of existential distress in patients with terminal cancer vary from 3 to 29%, depending on the operationalization of the concept”
From Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review (2022) · cites this paper as Pelletier et al., 2002
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)
Hu, R. J. (2003) · Encyclopedia of the Neurological Sciences · doi:10.1016/b0-12-226870-9/01070-4 · Cited by 9,117
The functional assessment of cancer therapy scale: development and validation of the general measure
Cella, D. F., Tulsky, D. S., Gray, G., Sarafian, B., Linn, E., Bonomi, A., Silberman, M., Yellen, S. B., Winicour, P., & Brannon, J. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.3.570 · Cited by 6,020 · cited 4×
“Overall, the results obtained by the patients in this study do not differ significantly from those obtained by FACT-BR normative sample [25] or from the scores obtained by the normative sample for the FACT-G [33] (none of the t-tests were significant) (Table 3).”
MethodResultInfluentialThe Psychology of Religion and Coping: Theory Research Practice
Barrett, J. L., & Pargament, K. I. (1998) · Review of Religious Research · doi:10.2307/3512468 · Cited by 2,610
The Psychology of Religion and Coping
McFadden, S. H., & Pargament, K. I. (1998) · Journal for the Scientific Study of Religion · doi:10.2307/1387534 · Cited by 1,441
Decision making during serious illness: What role do patients really want to play?
Degner, L. F., & Sloan, J. A. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90110-9 · Cited by 1,008 · cited 3×
“Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues Guy Pelletier1, Marja J. Verhoef2, Nasreen Khatri3 and Neil Hagen4,5,6 1Department of Psychosocial Resources, Tom Baker Cancer Centre, 2Department of Community Health Sciences, 3Depart…”
MethodInfluentialFine, H. A., Dear, K. B. G., Loeffler, J. S., Mc Black, P. L., & Canellos, G. P. (1993) · Cancer · doi:10.1002/1097-0142(19930415)71:8<2585::aid-cncr2820710825>3.0.co;2-s · Cited by 864 · cited 1×
“For example, even with aggressive radiation and chemotherapy regimes, the median survival for patients with grade 4 astrocytoma (glioblastoma multiforme or GBM) is about 12 months, and for grade 3 gliomas it is about 36 months [4].”
BackgroundA case for including spirituality in quality of life measurement in oncology
Brady, M. J., Peterman, A. H., Fitchett, G., Mo, M., & Cella, D. (1999) · Psycho-Oncology · doi:10.1002/(sici)1099-1611(199909/10)8:5<417::aid-pon398>3.0.co;2-4 · Cited by 835 · cited 1×
“[20] found that spirituality as measured by the functional assessment of chronic illness therapyspirituality (FACIT-Sp) correlated with general QOL to the same extent as physical well-being.”
BackgroundCohen, S. R., Mount, B. M., Strobel, M. G., & Bui, F. (1995) · Palliative Medicine · doi:10.1177/026921639500900306 · Cited by 738 · cited 9×
“This 7-item subscale is part of the MQOL, a multidimensional QOL questionnaire designed for use at all phases of the disease trajectory in patients with life-threatening diseases.”
MethodInfluentialPsychometric evaluation of the Beck Depression Inventory-II with primary care medical patients.
Arnau, R. C., Meagher, M. W., Norris, M. P., & Bramson, R. (2001) · Health Psychology · doi:10.1037/0278-6133.20.2.112 · Cited by 694 · cited 1×
“A recent study demonstrated the validity and the usefulness of the BDI-II in the detection of depression in primary care medical patients [27].”
Background
Research works printed but not linked: 3
- Beck A, Steer RA, Brown GK: Manual for the Beck Depression Inventory-II. The Psychological Corporation, New York, 1996
- Craighead WE, Craighead L, Ilardi SS: Psychosocial treatments for major depressive disorder. In: Nathan PE, Gorman JM (eds) A Guide to Treatments that Work. Oxford University Press, New York, 1998, pp 226-239
- Simpson S: Management of depression in cancer patients. Perspectives in Depression 8: 1-5, 2000
Cited by
(2020) · doi:10.1056/nejmra1907805 · Cited by 634
Incidence of Suicide in Persons With Cancer
Misono, S., Weiss, N. S., Fann, J. R., Redman, M., & Yueh, B. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.8941 · Cited by 608
Comorbid depression in medical diseases
Gold, S. M., Köhler-Forsberg, O., Moss-Morris, R., Mehnert, A., Miranda, J. J., Bullinger, M., Steptoe, A., Whooley, M. A., & Otte, C. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0200-2 · Cited by 534
Mitchell, A. J., Benito-León, J., González, J.-M. M., & Rivera-Navarro, J. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70166-6 · Cited by 519
Psychiatric disorders in advanced cancer
Miovic, M., & Block, S. (2007) · Cancer · doi:10.1002/cncr.22980 · Cited by 376
“Depression is associated with decreased adherence to treatment, prolonged hospital stays, and reduced quality of life.(45,46) It is a major risk factor for desire to hasten death,(9,47,48) and as many as 59% of terminally ill patients who request assisted suicide are depressed.”
BackgroundDepression in cancer: The many biobehavioral pathways driving tumor progression
Bortolato, B., Hyphantis, T. N., Valpione, S., Perini, G., Maes, M., Morris, G., Kubera, M., Köhler, C. A., Fernandes, B. S., Stubbs, B., et al. (2017) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2016.11.004 · Cited by 375
“In fact, depression is an independent predictor of more frequent and longer hospitalizations, diminished quality of life and decreased compliance to treatments [3].”
BackgroundDepression in cancer: new developments regarding diagnosis and treatment
Raison, C. L., & Miller, A. H. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00413-x · Cited by 336
Czarny, P., Wigner, P., Galecki, P., & Sliwinski, T. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.06.036 · Cited by 310
“There are numerous reports, including meta-analyses, which indicate that depressed patients suffering from cancer have a worse prognosis, an increased risk of non-adherence of medications, increased mortality and hospitalization time [Satin et al. 2009, Pelletier et al. 2002, Fann et al. 2008].”
BackgroundTreatment of existential distress in life threatening illness: A review of manualized interventions
LeMay, K., & Wilson, K. G. (2008) · Clinical Psychology Review · doi:10.1016/j.cpr.2007.07.013 · Cited by 280
Quality of life in adults with brain tumors: Current knowledge and future directions
Liu, R., Page, M., Solheim, K., Fox, S., & Chang, S. M. (2009) · Neuro-Oncology · doi:10.1215/15228517-2008-093 · Cited by 252
Depression in Cerebral Glioma Patients: A Systematic Review of Observational Studies
Rooney, A. G., Carson, A., & Grant, R. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq458 · Cited by 217
“There are conflicting observational data from glioma patients regarding associations between depression and sex (13,15), functional status (13,21), past psychiatric history (4,14), tumor size (15,24), tumor laterality (24,25), tumor grade (5,26), the affected lobe of the brain (14,21), steroid treatment (1,25), radiot…”
BackgroundMethodResultInfluentialSymptoms and problems in the end-of-life phase of high-grade glioma patients
Sizoo, E. M., Braam, L., Postma, T. J., Pasman, H. R. W., Heimans, J. J., Klein, M., Reijneveld, J. C., & Taphoorn, M. J. B. (2010) · Neuro-Oncology · doi:10.1093/neuonc/nop045 · Cited by 215
Psychiatric aspects of brain tumors: A review
Madhusoodanan, S., Ting, M. B., Farah, T., & Ugur, U. (2015) · World Journal of Psychiatry · doi:10.5498/wjp.v5.i3.273 · Cited by 209
Review on Quality of Life Issues in Patients with Primary Brain Tumors
Taphoorn, M. J. B., Sizoo, E. M., & Bottomley, A. (2010) · The Oncologist · doi:10.1634/theoncologist.2009-0291 · Cited by 189
Compromised Health-Related Quality of Life in Patients With Low-Grade Glioma
Aaronson, N. K., Taphoorn, M. J. B., Heimans, J. J., Postma, T. J., Gundy, C. M., Beute, G. N., Slotman, B. J., & Klein, M. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.5750 · Cited by 191
Medical management of patients with brain tumors
Wen, P. Y., Schiff, D., Kesari, S., Drappatz, J., Gigas, D. C., & Doherty, L. (2006) · Journal of Neuro-Oncology · doi:10.1007/s11060-006-9193-2 · Cited by 191
“and significantly affects the quality of life of these patients [187, 188].”
BackgroundProspective Study of Quality of Life in Adults with Newly Diagnosed High-grade Gliomas
Brown, P. D., Ballman, K. V., Rummans, T. A., Maurer, M. J., Sloan, J. A., Boeve, B. F., Gupta, L., Tang-Wai, D. F., Arusell, R. M., Clark, M. M., et al. (2006) · Journal of Neuro-Oncology · doi:10.1007/s11060-005-7020-9 · Cited by 192
“Another explantation is the close relation between fatigue and QOL [65], because many studies have reported a relation between QOL and disease status [8,47,55].”
BackgroundBrain Hodotopy: From Esoteric Concept to Practical Surgical Applications
De Benedictis, A., & Duffau, H. (2011) · Neurosurgery · doi:10.1227/neu.0b013e3182124690 · Cited by 188
“For example, in neurooncology, several clinical studies report a significant incidence of patients who develop disorders of high-level neurocognitive functions (executive, attentional, and emotional) with negative consequences on the quality of social, professional, emotional, and family life and prognosis.(179-181) S…”
BackgroundPsychosocial and supportive-care needs in high-grade glioma
Catt, S., Chalmers, A., & Fallowfield, L. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70230-4 · Cited by 183
The biology of depression in cancer and the relationship between depression and cancer progression
Sotelo, J. L., Musselman, D., & Nemeroff, C. (2014) · International Review of Psychiatry · doi:10.3109/09540261.2013.875891 · Cited by 179
“…medical outcomes in these patients by resulting in an increase in length of hospitalizations, diminishing quality of life, a reduction in the ability to care for oneself, and a decrease in compliance with treatments (Koenig et al., 1989, 1992; Pelletier et al., 2002; Stoudemire & Thompson, 1983).”
BackgroundThe influence of cognitive impairment on health-related quality of life in neurological disease
Mitchell, A. J., Kemp, S., Benito-León, J., & Reuber, M. (2010) · Acta Neuropsychiatrica · doi:10.1111/j.1601-5215.2009.00439.x · Cited by 171
“Neuropsychiatric symptoms and communication difficulties have been strongly associated with high perceived disease burden (28).”
BackgroundPsychological Issues in End-of-Life Care
Block, S. D. (2006) · Journal of Palliative Medicine · doi:10.1089/jpm.2006.9.751 · Cited by 171
Bunevičius, A. (2017) · Health and Quality of Life Outcomes · doi:10.1186/s12955-017-0665-1 · Cited by 178
“Mood symptoms and disorders are common [25–27] and were document as independent predictors of worse HRQoL of brain tumor patients [3, 26].”
BackgroundKesler, S. R., Lacayo, N. J., & Jo, B. (2011) · Brain Injury · doi:10.3109/02699052.2010.536194 · Cited by 162
“Paediatric cancer survivors tend to experience long-term fatigue, health issues and/or psychological difficulties [38, 39].”
BackgroundQuality of life among patients with a brain tumor and their carers.
Janda, M., Steginga, S., Langbecker, D., Dunn, J., Walker, D., & Eakin, E. (2007) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2007.06.018 · Cited by 176
“This is in line with several other studies, which demonstrated diminished survival prospective among brain tumour patients with depressed mood or changes in mental status – in particular among patients with low grade disease [13-16], and consistently, higher scores of depression were associated with lower quality of l…”
ResultArnold, S. D., Forman, L. M., Brigidi, B. D., Carter, K. E., Schweitzer, H. A., Quinn, H. E., Guill, A. B., Herndon, J. E., & Raynor, R. H. (2008) · Neuro-Oncology · doi:10.1215/15228517-2007-057 · Cited by 161
Patient suffering and caregiver compassion: new opportunities for research, practice, and policy.
Schulz, R., Hebert, R. S., Dew, M. A., Brown, S. L., Scheier, M. F., Beach, S. R., Czaja, S. J., Martire, L. M., Coon, D., Langa, K. M., et al. (2007) · The Gerontologist · doi:10.1093/geront/47.1.4 · Cited by 163
Symptom Clusters in Patients With High‐Grade Glioma
Fox, S. W., Lyon, D., & Farace, E. (2007) · Journal of Nursing Scholarship · doi:10.1111/j.1547-5069.2007.00144.x · Cited by 157
Schimmers, N., Breeksema, J. J., Smith-Apeldoorn, S. Y., Veraart, J., van den Brink, W., & Schoevers, R. A. (2022) · Psychopharmacology · doi:10.1007/s00213-021-06027-y · Cited by 162
“However, prevalence rates of existential distress in patients with terminal cancer vary from 3 to 29%, depending on the operationalization of the concept (Pelletier et al., 2002; De Faye et al., 2006; Wilson et al., 2007; LeMay and Wilson, 2008).”
BackgroundSupportive care needs of people with brain tumours and their carers
Janda, M., Eakin, E., Bailey, L., Walker, D., & Troy, K. (2006) · Supportive Care in Cancer · doi:10.1007/s00520-006-0074-1 · Cited by 159
“For some patients, 24-h supervision may become necessary [17, 31, 34].”
BackgroundLinking What We Eat to Our Mood: A Review of Diet, Dietary Antioxidants, and Depression
Huang, Q., Liu, H., Suzuki, K., Ma, S., & Liu, C. (2019) · Antioxidants · doi:10.3390/antiox8090376 · Cited by 144
Iconomou, G., Mega, V., Koutras, A., Iconomou, A. V., & Kalofonos, H. P. (2004) · Cancer · doi:10.1002/cncr.20385 · Cited by 140
Mainio, A., Hakko, H. H., Timonen, M., Niemelä, A., Koivukangas, J. P., & Räsänen, P. K. (2005) · Neurosurgery · doi:10.1227/01.neu.0000159648.44507.7f · Cited by 140
“The literature about psychiatric disorders in patients with a primary brain tumor has varied concerning the conceptualization and measurement of depression (36).”
BackgroundMethodFacets and determinants of quality of life in patients with recurrent high grade glioma
Gıovagnolı, A. R., Silvani, A., Colombo, E., & Boiardi, A. (2005) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.036186 · Cited by 140
“4 21 After the recurrence of a brain tumour, the evaluation and care of the QOL are even more important because treatments are not always expected to lengthen survival.”
BackgroundBoele, F. W., Douw, L., de Groot, M., van Thuijl, H. F., Cleijne, W., Heimans, J. J., Taphoorn, M. J. B., Reijneveld, J. C., & Klein, M. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not102 · Cited by 134
“All of these symptoms have a large impact on the everyday life of patients and may lead to a significant decrease in health-related quality of life (HRQOL).(8) It is suggested that effective treatment of these symptoms may increase HRQOL,(9) although an optimal strategy to reach this goal has not been defined yet.”
BackgroundPsychiatric symptoms in glioma patients: from diagnosis to management
Boele, F. W., Rooney, A. G., Grant, R., & Klein, M. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s65874 · Cited by 155
D'Angelo, C., Mirijello, A., Leggio, L., Ferrulli, A., Carotenuto, V., Icolaro, N., Miceli, A., D'Angelo, V., Gasbarrini, G., & Addolorato, G. (2008) · Journal of Neurosurgery · doi:10.3171/jns/2008/108/2/0281 · Cited by 124
Coyne, J. C., Palmer, S. C., Shapiro, P. J., Thompson, R., & DeMichele, A. (2004) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2003.08.012 · Cited by 123
Locke, D. E. C., Cerhan, J. H., Wu, W., Malec, J. F., Clark, M. M., Rummans, T. A., & Brown, P. D. (2008) · PubMed · Cited by 139
The relationships between depression and brain tumors
Litofsky, N. S., & Resnick, A. G. (2009) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-9825-4 · Cited by 126
“Other studies, including the Glioma Outcome Project, found that tumor location did not really impact the incidence of depression [1, 15, 41].”
BackgroundResultInfluentialMedical Management of Brain Tumor Patients
Drappatz, J., Schiff, D., Kesari, S., Norden, A. D., & Wen, P. Y. (2007) · Neurologic Clinics · doi:10.1016/j.ncl.2007.07.015 · Cited by 112
Goebel, S., & Mehdorn, H. M. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0501-5 · Cited by 117
The benefits of psychosocial interventions for cancer patients undergoing radiotherapy
Guo, Z., Tang, H.-Y., Li, H., Tan, S.-K., Feng, K.-H., Huang, Y.-C., Bu, Q., & Jiang, W. (2013) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-11-121 · Cited by 107
“Various studies have demonstrated that anxiety and depression are important and prevalent problems [3,4] that affect QOL in patients with cancer [5-8]; they also reduce compliance with treatment and prolong hospitalization [9,10], and can compound the physical consequences of the disease [11,12].”
BackgroundNeurological complications of systemic cancer
Khasraw, M., & Posner, J. B. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70220-9 · Cited by 108
Symptom management and quality of life in glioma patients
Boele, F. W., Klein, M., Reijneveld, J. C., Verdonck-de Leeuw, I. M., & Heimans, J. J. (2014) · CNS Oncology · doi:10.2217/cns.13.65 · Cited by 107
Association between depression and brain tumor: a systematic review and meta-analysis
Huang, J., Zeng, C., Xiao, J., Zhao, D., Tang, H., Wu, H., & Chen, J. (2017) · Oncotarget · doi:10.18632/oncotarget.19843 · Cited by 109
“17 studies assessed for depression or depressive symptoms using Hospital Anxiety and Depression Scale (HADS-D) [4, 7, 13, 14, 21, 33, 35, 39–43, 45, 46, 49–51], 6 used Beck Depression Inventory (BDI) [5, 6, 23, 44, 52, 54, 57], 2 used the Zung Self-Rating Depression Scale (Zung SDS) [51, 58], 2 used Diagnostic and Sta…”
BackgroundMethodInfluentialMainio, A., Hakko, H. H., Niemelä, A., Koivukangas, J. P., & Räsänen, P. K. (2005) · Journal of neurosurgery · doi:10.3171/jns.2005.103.5.0841 · Cited by 106
Mainio, A., Hakko, H. H., Niemelä, A., Koivukangas, J. P., & Räsänen, P. K. (2005) · European Psychiatry · doi:10.1016/j.eurpsy.2005.05.008 · Cited by 100
“BDI has been used in earlier studies evaluating depressive symptoms among patients with a primary brain tumor [12,24].”
BackgroundMethodInfluentialPhysical symptom profiles of depressed and nondepressed patients with cancer
Chen, M.-L., & Chang, H.-K. (2004) · Palliative Medicine · doi:10.1191/0269216304pm950oa · Cited by 94
What do 1281 distress screeners tell us about cancer patients in a community cancer center?
Kendall, J., Glaze, K., Oakland, S., Hansen, J., & Parry, C. (2011) · Psycho-Oncology · doi:10.1002/pon.1907 · Cited by 92
“The lack of recognition and resulting under-treatment of distress has been shown to contribute to a number of negative consequences: increased suffering [7], decreased quality of life for both patients and family members [8,9], reduced compliance with medical treatment [10,11], longer hospitalizations [12], and the po…”
BackgroundBunevičius, A., Tamašauskas, Š., Deltuva, V. P., Tamašauskas, A., Radžiūnas, A., & Bunevičius, R. (2013) · Acta Neurochirurgica · doi:10.1007/s00701-013-1930-7 · Cited by 95
“Indeed, positive association between depression and fatigue was previously documented in BT patients [38].”
BackgroundBoele, F. W., Klein, M., Verdonck-de Leeuw, I. M., Cuijpers, P., Heimans, J. J., Snijders, T. J., Vos, M., Bosma, I., Tijssen, C. C., Reijneveld, J. C., et al. (2018) · Journal of Neuro-Oncology · doi:10.1007/s11060-017-2712-5 · Cited by 88
“Other supportive internet-based interventions have shown positive effects on HRQOL in cancer patients [45].”
BackgroundInfluentialThe caregivers’ perspective on the end-of-life phase of glioblastoma patients
Flechl, B., Ackerl, M., Sax, C., Oberndorfer, S., Calabek, B., Sizoo, E. M., Reijneveld, J. C., Crevenna, R., Keilani, M. Y., Gaiger, A., et al. (2013) · Journal of Neuro-Oncology · doi:10.1007/s11060-013-1069-7 · Cited by 92
“In concordance with the literature [27, 28, 29], fatigue was the most common symptom in patients with GBM during their”
MethodScreening for distress in patients with brain cancer using the NCCN's rapid screening measure
Keir, S. T., Calhoun‐Eagan, R. D., Swartz, J. J., Saleh, O. A., & Friedman, H. S. (2008) · Psycho-Oncology · doi:10.1002/pon.1271 · Cited by 87
“Given the poor prognosis of this aggressive cancer, patients and families face many existential concerns as well, often with little time to prepare, and in relative isolation [15].”
BackgroundOwnsworth, T., Hawkes, A. L., Steginga, S. K., Walker, D., & Shum, D. (2009) · Disability and Rehabilitation · doi:10.1080/09638280802509538 · Cited by 88
“However, in other studies, both gender and age were unrelated to presence of mood disorder ([54], QoM 4/7), level of psychological distress ([55] QoM1⁄4 3/7; [56], QoM1⁄4 3/7; [57] QoM1⁄4 4/7) or quality of life ([58] QoM1⁄4 5/7; [59] QoM1⁄4 6/7; [60] QoM1⁄4 5/7).”
BackgroundInfluentialSymptom experience in patients with primary brain tumours: A longitudinal exploratory study
Molassiotis, A., Wilson, B., Brunton, L., Chaudhary, H. A., Gattamaneni, R., & McBain, C. A. (2010) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2010.03.001 · Cited by 85
“Depression has been identified as the single most important symptom predicting quality of life in a cohort of 73 patients with primary brain tumours (Pelletier et al., 2002).”
BackgroundSchulz, R., Beach, S. R., Hebert, R. S., Martire, L. M., Monin, J. K., Tompkins, C. A., & Albert, S. M. (2009) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e318198775b · Cited by 82
“The type and magnitude of disability associated with an illness may be no more important than the suffering engendered by the illness in terms of its impact on family members.(7,29,30) Furthermore, gaining an understanding of the role of suffering presents new opportunities for assessment and intervention for both pat…”
The Potential Role of Exercise in Neuro-Oncology
Cormie, P., Nowak, A. K., Chambers, S. K., Galvao, D. A., & Newton, R. U. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00085 · Cited by 90
Distress and quality of life in primary high-grade brain tumor patients
Kvale, E. A., Murthy, R. K., Taylor, R. A., Lee, J. Y., & Nabors, B. (2009) · Supportive Care in Cancer · doi:10.1007/s00520-008-0551-9 · Cited by 81
“Fatigue has been noted in a number of studies in highgrade-glioma patients [1, 19 ].”
BackgroundOwnsworth, T., Chambers, S., Damborg, E., Casey, L., Walker, D. G., & Shum, D. H. K. (2015) · Psycho-Oncology · doi:10.1002/pon.3687 · Cited by 74
Bergo, E., Lombardi, G., Guglieri, I., Capovilla, E. D., Pambuku, A., & Zagone, V. (2015) · European Journal of Cancer Care · doi:10.1111/ecc.12410 · Cited by 78
Predictors of distress and poorer quality of life in High Grade Glioma patients
Halkett, G. K. B., Lobb, E. A., Rogers, M. M., Shaw, T., Long, A. P., Wheeler, H., & Nowak, A. K. (2015) · Patient Education and Counseling · doi:10.1016/j.pec.2015.01.002 · Cited by 82
Fatigue among patients with brain tumors
Asher, A., Fu, J. B., Bailey, C. S. L., & Hughes, J. K. (2016) · CNS Oncology · doi:10.2217/cns-2015-0008 · Cited by 83
Living with a brain tumor: Reaction profiles in patients and their caregivers
Petruzzi, A., Finocchiaro, C. Y., Lamperti, E., & Salmaggi, A. (2012) · Supportive Care in Cancer · doi:10.1007/s00520-012-1632-3 · Cited by 76
“Mood and cognitive changes may include depression, dementia, anxiety, aggressive, memory and attention impairments [6, 7].”
BackgroundDepression in glioma: a primer for clinicians and researchers
Rooney, A. G., Brown, P. D., Reijneveld, J. C., & Grant, R. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-306497 · Cited by 80
Shaffrey, M. E., Mut, M., Asher, A. L., Burri, S. H., Chahlavi, A., Chang, S. M., Farace, E., Fiveash, J. B., Hentschel, S. J., Lang, F. F., et al. (2004) · Current Problems in Surgery · doi:10.1067/j.cpsurg.2004.06.001 · Cited by 76
Arber, A., Faithfull, S., Plaskota, M., Lucas, C., & de Vries, K. (2010) · International Journal of Palliative Nursing · doi:10.12968/ijpn.2010.16.1.46180 · Cited by 76
“It is well known that radiotherapy treatment causes neurological toxicity , and fatigue is identifi ed as present at diagnosis of PMBT , and is negatively correlated with maintaining a good quality of life ( Lovely et al , 1999 ; Pelletier et al , 2002 ) .”
BackgroundRandazzo, D. M., & Peters, K. B. (2016) · CNS Oncology · doi:10.2217/cns-2016-0010 · Cited by 78
Neurocognitive Deficits and Neurocognitive Rehabilitation in Adult Brain Tumors
Day, J., Gillespie, D. C., Rooney, A. G., Bulbeck, H., Zienius, K., Boele, F. W., & Grant, R. (2016) · Current Treatment Options in Neurology · doi:10.1007/s11940-016-0406-5 · Cited by 75
Keeling, M., Bambrough, J., & Simpson, J. (2012) · Psycho-Oncology · doi:10.1002/pon.3158 · Cited by 76
“However, the relationship between gender and higher levels of psychological distress has not always been substantiated by other studies [11] nor have significant associations between tumour location and tumour type to distress [7,12].”
ResultThe burden of brain tumor: a single-institution study on psychological patterns in caregivers
Finocchiaro, C. Y., Petruzzi, A., Lamperti, E., Botturi, A., Gaviani, P., Silvani, A., Sarno, L., & Salmaggi, A. (2011) · Journal of Neuro-Oncology · doi:10.1007/s11060-011-0726-y · Cited by 76
Screening for Distress in Routine Oncological Care—A Survey in 520 Melanoma Patients
Loquai, C., Scheurich, V., Syring, N., Schmidtmann, I. M., Rietz, S., Werner, A. T., Grabbe, S., & Beutel, M. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066800 · Cited by 72
“There is evidence that psychological distress is associated with decreased adherence to treatment regimes, lower quality of life, reduced enrollment in follow-up programs, delay in seeking medical advice, increased recurrence rates and mortality, and increased medical costs [8–18].”
BackgroundMilbury, K., Li, J., Weathers, S.-P., Mallaiah, S., Armstrong, T., Li, Y., Bruera, E., & Cohen, L. (2019) · Neuro-Oncology Practice · doi:10.1093/nop/npy052 · Cited by 63
Health-related quality of life in patients with high-grade glioma
Cheng, J., Zhang, X., & Liu, B.-L. (2008) · Neuro-Oncology · doi:10.1215/15228517-2008-050 · Cited by 69
Milbury, K., Weathers, S.-P., Durrani, S., Li, Y., Whisenant, M., Li, J., Lim, B., Weinberg, J. S., Kesler, S. R., Cohen, L., et al. (2020) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2020.02.004 · Cited by 68
Yoga Program for High-Grade Glioma Patients Undergoing Radiotherapy and Their Family Caregivers
Milbury, K., Mallaiah, S., Mahajan, A., Armstrong, T. S., Weathers, S.-P., Moss, K. E., Goktepe, N., Spelman, A. R., & Cohen, L. G. (2017) · Integrative Cancer Therapies · doi:10.1177/1534735417689882 · Cited by 68
“Exclusion criteria included the following: (1) regularly (self-defined) participated in a yoga practice in the year prior to diagnosis, (2) had a physicianrated life expectancy of less than 6 months, and (3) experienced cognitive deficits that would impede the completion of self-report instruments as determined by the…”
BackgroundMethodInfluentialArmstrong, T. S., Bishof, A. M., Brown, P. D., Klein, M., TAPHOORN, M. J. B., & Theodore‐Oklota, C. (2016) · Neuro-Oncology · doi:10.1093/neuonc/nov267 · Cited by 63
Goebel, S., & Mehdorn, H. M. (2012) · Supportive Care in Cancer · doi:10.1007/s00520-012-1675-5 · Cited by 63
“Quality of life As screening tool for global Health Related Quality of Life (HRQoL), two questions from the “European Organisation for Research and Treatment of Cancer core Quality of Life Questionnaire” (EORTC QLQ C-30) [23] were applied: question 29 (“How would you rate your overall health during the past week?”) an…”
ResultInfluentialHealth-related quality of life in high-grade glioma patients: a prospective single-center study
Yavaş, Ç., Zorlu, F., Özyiğit, G., Gurkaynak, M., Yavaş, G., Yüce, D., Cengiz, M., Yıldız, F., & Akyol, F. H. (2011) · Supportive Care in Cancer · doi:10.1007/s00520-011-1340-4 · Cited by 67
“been considered to be the main predictor for poor HRQoL and survival in patients with brain tumors [31, 41, 42].”
BackgroundOwnsworth, T., & Nash, K. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00096 · Cited by 69
Fear of cancer recurrence and death anxiety: unaddressed concerns for adult neuro-oncology patients
Loughan, A. R., Lanoye, A., Aslanzadeh, F. J., Villanueva, A. A. L., Boutte, R., Husain, M., & Braun, S. (2021) · Journal of Clinical Psychology in Medical Settings · doi:10.1007/s10880-019-09690-8 · Cited by 60
Improvement in cognitive function after surgery for low-grade glioma
Barzilai, O., Moshe, S. B., Sitt, R., Sela, G., Shofty, B., & Ram, Z. (2018) · Journal of neurosurgery · doi:10.3171/2017.9.jns17658 · Cited by 61
Piil, K., Jakobsen, J., Christensen, K. B., Juhler, M., & Jarden, M. (2015) · Journal of Neuro-Oncology · doi:10.1007/s11060-015-1821-2 · Cited by 67
“Further, depression is the most independent predictor of HRQOL in patients with brain tumors [11].”
BackgroundInterventions for the management of fatigue in adults with a primary brain tumour
Day, J., Yust‐Katz, S., Cachia, D., Wefel, J. S., Katz, L. H., Lukats, I. W. T., Bulbeck, H., Armstrong, T. S., & Rooney, A. G. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011376.pub2 · Cited by 64
Head, B. A., Schapmire, T. J., Keeney, C. E., Deck, S. M., Studts, J. L., Hermann, C. P., Scharfenberger, J. A., & Pfeifer, M. (2011) · Quality of Life Research · doi:10.1007/s11136-011-9934-3 · Cited by 59
“In another study of brain tumor patients, researchers found that distress (symptoms of depression) explained more than half of the variance in QOL [6].”
BackgroundPapuć, E., & Stelmasiak, Z. (2012) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2011.11.012 · Cited by 58
Depression and anxiety in glioma patients
van der Meer, P. B., Dirven, L., Hertler, C., Boele, F. W., Batalla, A., Walbert, T., Rooney, A. G., & Koekkoek, J. A. F. (2023) · Neuro-Oncology Practice · doi:10.1093/nop/npad019 · Cited by 64
Comelli, I., Lippi, G., Campana, V., Servadei, F., & Cervellin, G. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.06.12 · Cited by 69
Depressive symptoms and executive function in relation to survival in patients with glioblastoma
Noll, K. R., Sullaway, C. M., & Wefel, J. S. (2019) · Journal of Neuro-Oncology · doi:10.1007/s11060-018-03081-z · Cited by 61
“In addition to comprising the single largest influence upon quality of life in patients with malignant glioma [8, 9], evidence indicates that depression also has a detrimental impact upon survival [5, 10].”
BackgroundBunevičius, A., Deltuva, V. P., Tamašauskas, Š., Tamašauskas, A., & Bunevičius, R. (2012) · Psycho-Oncology · doi:10.1002/pon.3237 · Cited by 60
Bauwens, S., Baillon, C., Distelmans, W., & Theuns, P. (2009) · Psycho-Oncology · doi:10.1002/pon.1425 · Cited by 54
“Underestimation and the resulting inadequate treatment of distress and emotional disorders may lead to a number of negative consequences such as low therapy compliance [10], prolonged hospitalization [11], lower satisfaction with medical care [12,13], reduced quality of life of patients and their relatives [14–17] and…”
BackgroundNeurocognitive and sociodemographic functioning of glioblastoma long-term survivors
Flechl, B., Ackerl, M., Sax, C., Dieckmann, K., Crevenna, R., Gaiger, A., Widhalm, G., Preusser, M., & Marosi, C. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-012-0897-1 · Cited by 54
“Fatigue has been reported as one of the most common symptoms of brain tumor patients and one of the leading symptoms of decreasing quality of life [9, 38].”
BackgroundInfluentialGapstur, R., Gross, C. R., & Ness, K. (2009) · Oncology Nursing Forum · doi:10.1188/09.onf.723-731 · Cited by 53
“In follow-up studies of brain tumor survivors, sleep impairment negatively affected quality of life (Anderson et al., 2001; Hudson et al., 2003; Mostow, Byrne, Connelly, & Mul-vihill, 1991; Pelletier, Verhoef, Khatri, & Hagen, 2002).”
BackgroundAssessment of psychological distress among cancer patients undergoing radiotherapy in Saudi Arabia
Almigbal, T. H., Almutairi, K. M., Fu, J. B., Vinluan, J. M., Alhelih, E. M., Alonazi, W. B., Batais, M. A., Alodhayani, A. A., & Mubaraki, M. A. (2019) · Psychology Research and Behavior Management · doi:10.2147/prbm.s209896 · Cited by 54
“Furthermore, cancer patients under psychological distress have reduced compliance with treatment and prolonged hospitalizations.(22,26) Identifying cancer patients who may be more likely to suffer from psychological distress over the cancer trajectory is essential to targeting the proper interventions and providing th…”
BackgroundTibbs, M. D., Huynh‐Le, M., Reyes, A., Macari, A. C., Karunamuni, R. A., Tringale, K. R., Burkeen, J., Marshall, D. C., Xu, R., McDonald, C. R., et al. (2020) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2020.07.002 · Cited by 53
Emotional and personality changes following brain tumour resection
Jenkins, L. M., Drummond, K. J., & Andrewes, D. G. (2016) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2015.12.007 · Cited by 50
“Most studies of emotion in patients with brain cancer have focused on mood changes such as depression [2], which have a large impact on quality of life [3].”
BackgroundDepression as a systemic disease
Sotelo, J. L., & Nemeroff, C. B. (2016) · Personalized Medicine in Psychiatry · doi:10.1016/j.pmip.2016.11.002 · Cited by 67
Bauwens, S., Baillon, C., Distelmans, W., & Theuns, P. (2014) · Psycho-Oncology · doi:10.1002/pon.3484 · Cited by 47
Wilkinson, J., Marmol, N. L., Godfrey, C., Wills, H., van Eijndhoven, Q., Botchway, E. N., Sood, N., Anderson, V., & Catroppa, C. (2018) · Neuropsychology Review · doi:10.1007/s11065-018-9370-z · Cited by 41
“In addition, people suffering from various types of injury to the brain, including stroke, brain tumours, traumatic brain injury (TBI), and meningitis, often report fatigue (Crichton et al. 2015; de Groot et al. 2003; Pelletier et al. 2002; Rönnbäck and Johansson 2012).”
Stress and intervention preferences of patients with brain tumors
Keir, S. T., Guill, A. B., Carter, K. E., & Friedman, H. S. (2006) · Supportive Care in Cancer · doi:10.1007/s00520-006-0087-9 · Cited by 47
“Psychological stress, in turn, may include anxiety, [21], depression [26], and fear of dying [22].”
Background
Metadata
- Authors
- Pelletier, G., Verhoef, M. J., Khatri, N., & Hagen, N.
- Affiliations
- University of Calgary (CA)
- ORCID
- Hagen, Neil
- Venue
- Journal of Neuro-Oncology
- Published
- 2002-03
- Volume
- 57
- Issue
- 1
- Pages
- 41-49
- ISSN
- 0167-594X (ISSN-L)
- 1573-7373
- OpenAlex
- W1574260815
- Cited by
- 362
- References
- 49
- Citations by year
- 2026: 8 · 2025: 2 · 2024: 17 · 2023: 9 · 2022: 18 · 2021: 13 · 2020: 23 · 2019: 16 · 2018: 26 · 2017: 24 · 2016: 21 · 2015: 28 · 2014: 12 · 2013: 19 · 2012: 20
- FWCI
- 2.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Journal of Neuro-Oncology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Owens Foundation
- Topics
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Childhood Cancer Survivors' Quality of Life
- Keywords
- quality of life, brain tumors, depression, fatigue, emotional distress, existential questions, neuropsychiatric symptoms, primary brain tumors, prevalence of depressive symptoms, McGill Quality of Life Questionnaire, predictors of quality of life
- MeSH terms
- Adult, Affective Symptoms, Brain Neoplasms, Depression, Fatigue, Female, Humans, Male, Middle Aged, Quality of Life, Surveys and Questionnaires, Regression Analysis, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.